Search clinical trials for: Intravascular Lithotripsy System of Shanghai MicroPort Rhythm
Total 166 results
-
Acasti Pharma Inc.Active, not recruitingAtaxia TelangiectasiaCanada
-
Samsung Medical CenterUnknownDepression | Adverse Reaction to DrugKorea, Republic of
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; National Multiple Sclerosis SocietyRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Ukrainian Medical Stomatological AcademyCompletedAdverse Effect | Atherosclerosis, Coronary | Insulin Resistance SyndromeUkraine
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedPharmacokinetics | Pharmacodynamics | Drug-induced QT ProlongationUnited States
-
National Institute of Mental Health (NIMH)CompletedBipolar DisorderUnited States
-
University of Erlangen-Nürnberg Medical SchoolRecruitingPsoriatic Arthritis | Withdrawal | ReductionGermany
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPlasma Cell MyelomaUnited States
-
HTL-Strefa S.A.Completed
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMultiple Myeloma | ISS Stage III Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterActive, not recruitingMyasthenia Gravis | Neuromyelitis Optica | Autoimmune Disease | Chronic Inflammatory Demyelinating Polyneuropathy | Lambert Eaton Myasthenic Syndrome | Cerebellar Degeneration | Stiff Person Syndrome | Opsoclonus Myoclonus Syndrome | Neurologic Autoimmune Disease | Autologous Transplant Autoimmune | Multiple... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkCompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Stage I Mantle Cell Lymphoma | Stage II Contiguous Mantle Cell Lymphoma | Stage II Non-Contiguous Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | t(9;22) | BCR-ABL1 Fusion Protein ExpressionUnited States
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States, Canada, Israel, Puerto Rico
-
M.D. Anderson Cancer CenterRecruitingRecurrent Adult Lymphoblastic Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent T Acute Lymphoblastic Leukemia | Refractory Lymphoblastic LymphomaUnited States